Diabetes Medication Rosiglitazone Carries Higher Risk Than Pioglitazone

In comparison to older adults administered pioglitazone, similar patients taking rosiglitazone have a higher risk of death and heart failure, according to an article released on November 24, 2008 in Archives of Internal Medicine, one of the JAMA/Archives journals.

More: continued here

Filed under: Diabetes on December 11th, 2008